BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21296819)

  • 1. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort.
    Stringham JM; Garcia PV; Smith PA; McLin LN; Foutch BK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7406-15. PubMed ID: 21296819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glare hypothesis of macular pigment function.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2007 Sep; 84(9):859-64. PubMed ID: 17873771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular pigment and visual performance under glare conditions.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin.
    Hammond BR; Fletcher LM; Elliott JG
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):476-81. PubMed ID: 23211814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS.
    Nolan JM; Loughman J; Akkali MC; Stack J; Scanlon G; Davison P; Beatty S
    Vision Res; 2011 Mar; 51(5):459-69. PubMed ID: 21237188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular pigment: a test of the acuity hypothesis.
    Engles M; Wooten B; Hammond B
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2922-31. PubMed ID: 17525229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision.
    Renzi LM; Hammond BR
    Ophthalmic Physiol Opt; 2010 Jul; 30(4):351-7. PubMed ID: 20492542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing performance while avoiding damage: a contribution of macular pigment.
    Stringham JM; Snodderly DM
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6298-306. PubMed ID: 23982840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of the AcrySof natural lens on glare disability and photostress.
    Hammond BR; Bernstein B; Dong J
    Am J Ophthalmol; 2009 Aug; 148(2):272-276.e2. PubMed ID: 19426959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.
    Aleman TS; Duncan JL; Bieber ML; de Castro E; Marks DA; Gardner LM; Steinberg JD; Cideciyan AV; Maguire MG; Jacobson SG
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1873-81. PubMed ID: 11431456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of macular pigment optical density using two different heterochromatic flicker photometers.
    Loane E; Stack J; Beatty S; Nolan JM
    Curr Eye Res; 2007 Jun; 32(6):555-64. PubMed ID: 17612971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma.
    Siah WF; O'Brien C; Loughman JJ
    Br J Ophthalmol; 2018 Jul; 102(7):929-935. PubMed ID: 28982957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between macular pigment and visual performance.
    Loughman J; Akkali MC; Beatty S; Scanlon G; Davison PA; O'Dwyer V; Cantwell T; Major P; Stack J; Nolan JM
    Vision Res; 2010 Jun; 50(13):1249-56. PubMed ID: 20394766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of lower macular pigment optical density in chronic open angle glaucoma.
    Igras E; Loughman J; Ratzlaff M; O'Caoimh R; O'Brien C
    Br J Ophthalmol; 2013 Aug; 97(8):994-8. PubMed ID: 23686328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration.
    Ciulla TA; Hammond BR
    Am J Ophthalmol; 2004 Oct; 138(4):582-7. PubMed ID: 15488784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery.
    Stringham JM; O'Brien KJ; Stringham NT
    Eye Vis (Lond); 2016; 3():30. PubMed ID: 27857944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of macular pigment on heterochromatic luminance contrast.
    Renzi LM; Hammond BR
    Exp Eye Res; 2010 Dec; 91(6):896-900. PubMed ID: 20883691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of photochromic lenses on visual performance.
    Renzi-Hammond LM; Hammond BR
    Clin Exp Optom; 2016 Nov; 99(6):568-574. PubMed ID: 27346784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.